Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy

Bone Marrow Transplantation

Volumn 44, Issue 1, 2009, Pages 43-49

  Inamoto, Y ^a,b   Ito, M ^a   Suzuki, R ^c   Nishida, T ^a,b   Iida, H ^d   Kohno, A ^e   Sawa, M ^f   Murata, M ^b   Nishiwaki, S ^a   Oba, T ^a   Yanada, M ^b   Naoe, T ^b   Ichihashi, R ^b   Fujino, M ^a   Yamaguchi, T ^a   Morishita, Y ^e   Hirabayashi, N ^a   Kodera, Y ^a   Miyamura, K ^a  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Meitetsu Hospital   (Japan)

^e Aichi Prefectural Welfare Federation of Agriculture Co operative Associations Konan Kosei Hospital   (Japan)

^f ANJO KOSEI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE; TACROLIMUS;

ABDOMINAL PAIN; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL FEATURE; COLITIS; COLONOSCOPY; CONTROLLED STUDY; DIARRHEA; ENTEROPATHY; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINAL TRANSPLANT ASSOCIATED MICROANGIOPATHY; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; COLITIS; CYTOMEGALOVIRUS INFECTIONS; DIARRHEA; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 67651087102     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.419     Document Type: Article

References (28)

1. Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS. Bone marrow transplant-associated thrombotic microangiopathy: A case series. Bone Marrow Transplant 1995; 15: 247-253.
2. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14: 495-504.
3. Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L et al. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: A survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2002; 118: 1112-1119.
4. Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 571-575.
5. Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A et al Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: Results of a consensus process by an International Working Group. Haematologica 2007; 92: 95-100.
6. Holler E, Kolb HJ, Hiller E, Mraz W, Lehmacher W, Gleixner B et al Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989; 73: 2018-2024.
7. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma. Transfusion 2004; 44 294-304.
8. Hahn T, Alam AR, Lawrence D, Ford L, Baer MR, Bambach B et al. Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion. Transplantation 2004; 78: 1515-1522.
9. Shimoni A, Yeshurun M, Hardan I, Avigdor A, Ben-Bassat I, Nagler A. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced. Biol Blood Marrow Transplant 2004; 10: 484-493.
10. Kojouri K, George JN. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol 2007; 19: 148-154.
11. Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K et al. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. Am J Hematol 2006; 81: 525-531.
12. Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation 2006; 82: 638-644.
13. Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA et al. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: Risk factors and response to treatment. Biol Blood Marrow Transplant 2007; 13 469-477.
14. Martinez MT, Bucher C, Stussi G, Heim D, Buser A, Tsakiris DA et al Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant 2005; 36: 993-1000.
15. Lewis GD, Campbell WB, Johnson AR. Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology 1986; 119: 62-69.
16. Cox GJ, Matsui SM, Lo RS, Hinds M, Bowden RA, Hackman RC et al. Etiology and outcome of diarrhea after marrow transplantation: A prospective study. Gastroenterology 1994; 107: 1398-1407.
17. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR et al. A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood 1990; 76: 1464-1472.
18. Deeg HJ. How I treat refractory acute GVHD. Blood 2007; 109: 4119-4126.
19. Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y et al. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: A clinical imitator of acute enteric graft-versus-host disease. Bone Marrow Transplant 2004; 33: 1143-1150.
20. Nadasdy T, Silva FG. Adult renal disease. In: Sternberg SS (ed). Diagnostic Surgical Pathology, 3rd edn, Lippincott Williams & Wilkins: Philadelphia, PA, 1999, pp 1736-1738.
21. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250-259.
22. Dee SL, Butt K, Ramaswamy G. Intestinal ischemia. Arch Pathol Lab Med 2002; 126: 1201-1204.
23. Couriel DR, Saliba R, Escalon MP, Hsu Y, Ghosh S, Ippoliti C et al Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol 2005; 130: 409-417.
24. CutlerC, Henry NL, Magee C, Li S, Kim HT, Alyea E et al. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 551-557.
25. Fujino M, Kim Y, Ito M. Intestinal thrombotic microangiopathy induced by FK506 in rats. Bone Marrow Transplant 2007; 39: 367-372.
26. KummerM, Lev A, Reiter Y, Biedermann BC. Vascular endothelial cells have impaired capacity to present immunodominant, antigenic peptides: A mechanism of cell type-specific immune escape. J Immunol 2005; 174: 1947-1953.
27. Ertault-Daneshpouy M, Leboeuf C, Lemann M, Bouhidel F, Ades L, Gluckman E et al. Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease. Blood 2004; 103: 4681-4684.
28. Sieg A, Hachmoeller-Eisenbach U, Eisenbach T. Prospective evaluation of complications in outpatient GI endoscopy: A survey among German gastroenterologists. Gastrointest Endosc 2001; 53: 620-627.